Loading clinical trials...
Loading clinical trials...
Surgical Excision Versus Combined Treatment With Curettage and Imiquimod for Nodular Basal Cell Carcinoma: an Open, Non-inferiority, Randomized Controlled Trial
Conditions
Interventions
Imiquimod 5% cream with prior curettage
Standard surgical excision
Locations
1
Netherlands
Maastricht University medical Centre
Maastricht, Limburg, Netherlands
Start Date
January 1, 2016
Primary Completion Date
December 1, 2017
Completion Date
December 1, 2022
Last Updated
September 24, 2021
NCT07144384
NCT06608238
NCT02018679
Lead Sponsor
Maastricht University Medical Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions